Skip to main content

Table 4 Effect of ivermectin and diazinon treatment on clinical score change of experimental camels

From: Epidemiological and therapeutic studies of camel mange in Fafan zone, Eastern Ethiopia

Group

D0

D7

D14

D21

D28

D42

D56

Ivermectin

1.83 ± 0.75b

1.67 ± 0.52b

1.33 ± 0.52b

1.00 ± 0.63ab

0.67 ± 0.52a

0.67 ± 0.82a

0.67 ± 0.52a

Diazinon

1.67 ± 0.82b

2.00 ± 0.90b

1.33 ± 0.52b

0.83 ± 0.41ab

0.33 ± 0.52a

0.67 ± 0.82a

0.50 ± 0.84a

Infested untreated

1.67 ± 0.82

1.13 ± 0.52

1.67 ± 0.82

2.17 ± 0.41

2.00 ± 0.63

2.17 ± 0.75

2. 33 ± 0.53

Healthy untreated

0.00 ± 0.00a

0.00 ± 0.00a

0.00 ± 0.00a

0.00 ± 0.00 a

0.00 ± 0.00a

0.00 ± 0.00a

0.33 ± 0.52a

  1. Values are mean ± SEM; n (number of animals in each group) = 6; D = day; D0 = the day treatment commenced; SEM = standard error of mean; all superscripts indicate significance at p < 0.05 (a compared to infested untreated; b compared to healthy untreated)